(Q40828965)

24 September 2017

title

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters (English)

1 reference

24 September 2017

1 reference

Fragaki K

1

1 reference

24 September 2017

Suffia I

2

1 reference

24 September 2017

Ferrua B

3

1 reference

24 September 2017

Rousseau D

4

1 reference

24 September 2017

Le Fichoux Y

5

1 reference

24 September 2017

Kubar J

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

13-14

1 reference

24 September 2017

page(s)

1701-1709

1 reference

Global control and Leishmania HIV co-infection

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Transmission of L. infantum by blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Recent strategies for the chemotherapy of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Reinfection in American cutaneous leishmaniasis: evaluation of clinical outcomes in the hamster model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

ISCOMs vaccine against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

DNA vaccination strategies against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

The scanning model for translation: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

10.1016/S0264-410X(00)00398-4

Identifiers

DOI

1 reference

24 September 2017

1 reference